cytarabine has been researched along with olaparib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HD; He, JX; Miao, ZH; Tian, YN; Wang, YT; Xu, L; Yuan, B; Zhang, A | 1 |
1 other study(ies) available for cytarabine and olaparib
Article | Year |
---|---|
Acquired resistance of phosphatase and tensin homolog-deficient cells to poly(ADP-ribose) polymerase inhibitor and Ara-C mediated by 53BP1 loss and SAMHD1 overexpression.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; PTEN Phosphohydrolase; SAM Domain and HD Domain-Containing Protein 1; Tumor Suppressor p53-Binding Protein 1 | 2018 |